menu
Biological Therapy Market Industry Trends Analysis Report by Technology, By End User & By Product
Biological Therapy Market Industry Trends Analysis Report by Technology, By End User & By Product
The rise in cancer cases globally boosts the global cancer biological therapy market in the forecast period As per the reports of the American Cancer Society Statistics in 2016, majority of cases of SCLC mostly occur in individuals between the age group of 60-80 years with an estimated global death rate being 30,000 per year

Biological Therapy Market Analysis and Size

Global Biological Therapy Market  in the forecast period 2022-2029. The expected CAGR of global biological therapy market  is tend to be around 9.32% in the mentioned forecast period. The market was valued at USD 350.21 billion in 2021, and it would grow upto USD 714.37 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Biological therapy is cancer treatment that uses the body's immune system to fight against cancerous cells without affecting the healthy cells. The biological drug therapy such as monoclonal antibodies exerts their action by either hindering the cancer growth or rise cell death. The different types of biological therapies are interferons, monoclonal antibodies, interleukins, and vaccines. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period

Global Biological Therapy Market Dynamics

Drivers

  • Increase in Cancer Cases

The rise in cancer cases globally boosts the global cancer biological therapy market in the forecast period As per the reports of the American Cancer Society Statistics in 2016, majority of cases of SCLC mostly occur in individuals between the age group of 60-80 years with an estimated global death rate being 30,000 per year. In addition to this, as per the reports of WHO, lung cancer is the second most dominant cancer in men and women causing 1.59 million deaths in 2012. This boost the market growth.

Global Cancer Biological Therapy Market Regional Analysis/Insights

The major countries covered in the global biological therapy market  are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Global Cancer Biological Therapy Market Share Analysis

Key players operating in the global biological therapy market include:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Lilly (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Endo Pharmaceuticals plc (Ireland)
  • Zydus Group (India)
  • Bausch Health Companies Inc. (Canada)

 

 

Access Full Report:-

https://www.databridgemarketresearch.com/reports/global-biological-therapy-market

COVID-19 Impact on Global Biological Therapy Market

The COVID-19 pandemic has had a significant detrimental influence on the global biological therapy market. The supply chain of biologics was disturbed because of the COVID-19 outbreak and lockdown. Hospitals and clinics are predominantly reserved for severe and critical COVID-19 patients. Researchers faced hurdles associated with different other diseases. The demand for several vaccinations and other preventative majors increased dramatically as a result of COVID-19. Since these vaccines were dominating the market, the impact of COVID-19 on the biologics market was minimal. However, in the post-pandemic era, the market showed a high rise and is expected to rise high in the upcoming years.

 

Request Access for Sample Report:-

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biological-therapy-market

 

Major TOC of the Report

1 INTRODUCTION

2 MARKET SEGMENTATION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

 

Get TOC of the Report:-  

https://www.databridgemarketresearch.com/toc/?dbmr=global-biological-therapy-market

 

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgeMarketresearch.com

 

Browse Related Reports@

Ø  Global Rare Disease Genetic Testing Market

Ø  Global Renal Denervation Market

Ø  Global Pemphigus Vulgaris Treatment Market

Ø  Global Medical Necessity Management Software Market

Ø  Global Healthcare Information Software Market

Ø  Global Immunoprotein Diagnostic Testing Market